These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3073804)

  • 1. Terbutaline and diaphragm function in chronic obstructive pulmonary disease: a double-blind randomized clinical trial.
    Stoller JK; Wiedemann HP; Loke J; Snyder P; Virgulto J; Matthay RA
    Br J Dis Chest; 1988 Jul; 82(3):242-50. PubMed ID: 3073804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a beta 2-agonist (broxaterol) on respiratory muscle strength and endurance in patients with COPD with irreversible airway obstruction.
    Nava S; Crotti P; Gurrieri G; Fracchia C; Rampulla C
    Chest; 1992 Jan; 101(1):133-40. PubMed ID: 1345900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.
    Murciano D; Auclair MH; Pariente R; Aubier M
    N Engl J Med; 1989 Jun; 320(23):1521-5. PubMed ID: 2498658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline and diaphragmatic contractility. Investigation of a dose-response relationship.
    Foxworth JW; Reisz GR; Knudson SM; Cuddy PG; Pyszczynski DR; Emory CE
    Am Rev Respir Dis; 1988 Dec; 138(6):1532-4. PubMed ID: 3059899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does inhaled albuterol improve diaphragmatic contractility in patients with chronic obstructive pulmonary disease?
    Hatipoğlu U; Laghi F; Tobin MJ
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1916-21. PubMed ID: 10588606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral terbutaline augments cardiac performance in chronic obstructive pulmonary disease.
    Chan CK; Loke J; Snyder PE; Wackers F; Mattera J; Matthay RA
    Am J Med Sci; 1988 Jul; 296(1):33-8. PubMed ID: 3044105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domiciliary nebulized terbutaline in severe chronic airways obstruction.
    Hansen NC; May O
    Eur Respir J; 1990 Apr; 3(4):463-4. PubMed ID: 2365041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral terbutaline in chronic airflow limitation.
    Maltbaek N; Garsdal P; Christensen H; Bro H; Rasmussen FV
    Chest; 1989 Jun; 95(6):1248-52. PubMed ID: 2721259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted inspiratory muscle training improves respiratory muscle function and reduces dyspnea in patients with chronic obstructive pulmonary disease.
    Harver A; Mahler DA; Daubenspeck JA
    Ann Intern Med; 1989 Jul; 111(2):117-24. PubMed ID: 2742247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.
    de Jong JW; Koëter GH; van der Mark TW; Postma DS
    Thorax; 1996 Jul; 51(7):684-8. PubMed ID: 8882073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease.
    Murciano D; Aubier M; Lecocguic Y; Pariente R
    N Engl J Med; 1984 Aug; 311(6):349-53. PubMed ID: 6738652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of inhaled terbutaline on FEV1, FVC, dyspnoea and walking distance in patients with chronic obstructive lung disease.
    Evald T; Keittelmann S; Sindrup JH; Lange P
    Respir Med; 1992 Mar; 86(2):93-6. PubMed ID: 1615190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A; Grieco A; Vibelli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of theophylline in chronic obstructive lung disease.
    Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardiorespiratory effects of oral terbutaline and an ephedrine-theophylline-phenobarbital combination: comparison in patients with chronic obstructive ventilatory disorders.
    Cohen BM
    Ann Allergy; 1978 Apr; 40(4):233-9. PubMed ID: 345887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor blockers and terbutaline in patients with chronic obstructive lung disease. Effects and interaction after oral administration.
    Wunderlich J; Macha HN; Wudicke H; Huckauf H
    Chest; 1980 Nov; 78(5):714-20. PubMed ID: 6107217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilator treatment for partially reversible chronic obstructive airways disease.
    Tandon MK; Kailis SG
    Thorax; 1991 Apr; 46(4):248-51. PubMed ID: 2038732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
    Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
    Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress of respiratory muscle dysfunction in patients with severe chronic obstructive disease].
    Montes de Oca M; Celli BR; Rassulo J
    Arch Bronconeumol; 1997 Dec; 33(11):561-5. PubMed ID: 9508471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of theophylline on respiratory muscle contractility and fatigue.
    Landsberg KF; Vaughan LM; Heffner JE
    Pharmacotherapy; 1990; 10(4):271-9. PubMed ID: 2201960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.